EPA:ALPAT - Euronext Paris - Matif - FR0010785790 - Common Stock - Currency: EUR
EPA:ALPAT (6/18/2025, 7:00:00 PM)
10.1
0 (0%)
The current stock price of ALPAT.PA is 10.1 EUR. In the past month the price decreased by -8.18%. In the past year, price decreased by -26.28%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1ABBV.MI | ABBVIE INC | 18.61 | 293.65B | ||
4AB.DE | ABBVIE INC | 17.98 | 283.33B | ||
AMG.DE | AMGEN INC | 13.95 | 135.29B | ||
GIS.DE | GILEAD SCIENCES INC | 14.08 | 117.83B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 99.95B | ||
1REGN.MI | REGENERON PHARMACEUTICALS | 11.92 | 49.56B | ||
ARGX.BR | ARGENX SE | 101.76 | 28.89B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 21.76B | ||
IDP.DE | BIOGEN INC | 8.05 | 16.21B | ||
1EXEL.MI | EXELIXIS INC | 18.83 | 9.81B | ||
1MRNA.MI | MODERNA INC | N/A | 8.71B | ||
0QF.DE | MODERNA INC | N/A | 8.48B |
Plant Advanced Technologies SA operates as a plant biotechnology company. The company is headquartered in Nancy, Grand Est. The company went IPO on 2015-04-08. The company is also engaged in the research and development in the field of plant biotechnology. The firm patented its own production technologies, such as PAT Plant Milking, active natural compounds production system based on roots exudation of plants grown hydroponically or PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous to produce outside their leaf, in a sterile closed pitcher, the protein of interest in liquid. In addition PAT is involved in the development and sale of know-how, licenses and sub-licenses for its technologies.
PLANT ADVANCED TECHNOLOGIES
19 Avenue de la Foret de Haye
Nancy GRAND EST FR
Employees: 27
Phone: 33383940342
The current stock price of ALPAT.PA is 10.1 EUR.
The exchange symbol of PLANT ADVANCED TECHNOLOGIES is ALPAT and it is listed on the Euronext Paris - Matif exchange.
ALPAT.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ALPAT.PA and the average price target is 11.73 EUR. This implies a price increase of 16.14% is expected in the next year compared to the current price of 10.1. Check the PLANT ADVANCED TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) has a market capitalization of 11.31M EUR. This makes ALPAT.PA a Nano Cap stock.
PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) currently has 27 employees.
PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) has a support level at 10.05 and a resistance level at 10.45. Check the full technical report for a detailed analysis of ALPAT.PA support and resistance levels.
The Revenue of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) is expected to grow by 13.04% in the next year. Check the estimates tab for more information on the ALPAT.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALPAT.PA does not pay a dividend.
PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) will report earnings on 2025-10-29.
The PE ratio for PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) is 12.02. This is based on the reported non-GAAP earnings per share of 0.84 and the current share price of 10.1 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ALPAT.PA.
ChartMill assigns a fundamental rating of 5 / 10 to ALPAT.PA. ALPAT.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months ALPAT.PA reported a non-GAAP Earnings per Share(EPS) of 0.84. The EPS increased by 1057.93% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 48.52% | ||
ROA | 5.85% | ||
ROE | 9.95% | ||
Debt/Equity | 0.19 |
ChartMill assigns a Buy % Consensus number of 84% to ALPAT.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 97.01% and a revenue growth 13.04% for ALPAT.PA